HEADER MEMBRANE PROTEIN 15-MAR-21 7NVH
TITLE CRYO-EM STRUCTURE OF THE MYCOLIC ACID TRANSPORTER MMPL3 FROM M.
TITLE 2 TUBERCULOSIS
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: TREHALOSE MONOMYCOLATE EXPORTER MMPL3;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: TMM EXPORTER MMPL3,MMPL3 TRANSPORTER,MYCOBACTERIAL MEMBRANE
COMPND 5 PROTEIN LARGE 3;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS;
SOURCE 3 ORGANISM_TAXID: 1773;
SOURCE 4 GENE: MMPL3, RV0206C, MTCY08D5.01C, MTV033.14C;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS TRANSPORTER, MEMBRANE PROTEIN
EXPDTA ELECTRON MICROSCOPY
AUTHOR O.ADAMS,J.C.DEME,J.L.PARKER,S.M.LEA,S.NEWSTEAD
REVDAT 5 10-JUL-24 7NVH 1 COMPND REMARK HETNAM HETSYN
REVDAT 4 21-DEC-22 7NVH 1 COMPND SOURCE JRNL DBREF
REVDAT 4 2 1 SEQADV
REVDAT 3 20-OCT-21 7NVH 1 JRNL
REVDAT 2 21-JUL-21 7NVH 1 JRNL
REVDAT 1 16-JUN-21 7NVH 0
JRNL AUTH O.ADAMS,J.C.DEME,J.L.PARKER,P.W.FOWLER,S.M.LEA,S.NEWSTEAD
JRNL TITL CRYO-EM STRUCTURE AND RESISTANCE LANDSCAPE OF M.
JRNL TITL 2 TUBERCULOSIS MMPL3: AN EMERGENT THERAPEUTIC TARGET.
JRNL REF STRUCTURE V. 29 1182 2021
JRNL REFN ISSN 0969-2126
JRNL PMID 34242558
JRNL DOI 10.1016/J.STR.2021.06.013
REMARK 2
REMARK 2 RESOLUTION. 3.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 SOFTWARE PACKAGES : NULL
REMARK 3 RECONSTRUCTION SCHEMA : NULL
REMARK 3
REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT
REMARK 3 PDB ENTRY : NULL
REMARK 3 REFINEMENT SPACE : NULL
REMARK 3 REFINEMENT PROTOCOL : NULL
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL
REMARK 3
REMARK 3 FITTING PROCEDURE : NULL
REMARK 3
REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS
REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL
REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL
REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.000
REMARK 3 NUMBER OF PARTICLES : 414082
REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE
REMARK 3 CORRECTION
REMARK 3
REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL
REMARK 3
REMARK 3 OTHER DETAILS: NULL
REMARK 4
REMARK 4 7NVH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-MAR-21.
REMARK 100 THE DEPOSITION ID IS D_1292114642.
REMARK 245
REMARK 245 EXPERIMENTAL DETAILS
REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE
REMARK 245 SPECIMEN TYPE : NULL
REMARK 245
REMARK 245 ELECTRON MICROSCOPE SAMPLE
REMARK 245 SAMPLE TYPE : PARTICLE
REMARK 245 PARTICLE TYPE : POINT
REMARK 245 NAME OF SAMPLE : MYCOLIC ACID TRANSPORTER MMPL3
REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 2.00
REMARK 245 SAMPLE SUPPORT DETAILS : NULL
REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL
REMARK 245 SAMPLE BUFFER : NULL
REMARK 245 PH : 7.50
REMARK 245 SAMPLE DETAILS : NULL
REMARK 245
REMARK 245 DATA ACQUISITION
REMARK 245 DATE OF EXPERIMENT : NULL
REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL
REMARK 245 TEMPERATURE (KELVIN) : NULL
REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS
REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X
REMARK 245 4K)
REMARK 245 MINIMUM DEFOCUS (NM) : NULL
REMARK 245 MAXIMUM DEFOCUS (NM) : NULL
REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL
REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL
REMARK 245 NOMINAL CS : NULL
REMARK 245 IMAGING MODE : BRIGHT FIELD
REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5820.00
REMARK 245 ILLUMINATION MODE : FLOOD BEAM
REMARK 245 NOMINAL MAGNIFICATION : NULL
REMARK 245 CALIBRATED MAGNIFICATION : NULL
REMARK 245 SOURCE : FIELD EMISSION GUN
REMARK 245 ACCELERATION VOLTAGE (KV) : 300
REMARK 245 IMAGING DETAILS : NULL
REMARK 247
REMARK 247 ELECTRON MICROSCOPY
REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON
REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE
REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES
REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION
REMARK 247 OF THE STRUCTURE FACTORS.
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 LEU A 343
REMARK 465 GLY A 344
REMARK 465 VAL A 345
REMARK 465 ARG A 346
REMARK 465 THR A 347
REMARK 465 LEU A 348
REMARK 465 PHE A 349
REMARK 465 ARG A 350
REMARK 465 VAL A 351
REMARK 465 PRO A 352
REMARK 465 PHE A 353
REMARK 465 LEU A 354
REMARK 465 ALA A 355
REMARK 465 ASN A 356
REMARK 465 TRP A 357
REMARK 465 LYS A 358
REMARK 465 ILE A 359
REMARK 465 SER A 360
REMARK 465 ALA A 361
REMARK 465 ALA A 362
REMARK 465 TYR A 363
REMARK 465 LEU A 364
REMARK 465 ASN A 365
REMARK 465 TRP A 366
REMARK 465 LEU A 367
REMARK 465 ALA A 368
REMARK 465 ASP A 369
REMARK 465 ARG A 370
REMARK 465 LEU A 371
REMARK 465 GLN A 372
REMARK 465 ARG A 373
REMARK 465 THR A 374
REMARK 465 LYS A 375
REMARK 465 THR A 376
REMARK 465 ARG A 377
REMARK 465 ASP A 753
REMARK 465 GLY A 754
REMARK 465 SER A 755
REMARK 465 GLU A 756
REMARK 465 ASN A 757
REMARK 465 LEU A 758
REMARK 465 TYR A 759
REMARK 465 PHE A 760
REMARK 465 GLN A 761
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O ILE A 323 OG1 THR A 327 2.14
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ARG A 65 52.20 -92.73
REMARK 500 ARG A 96 -3.78 77.26
REMARK 500 ASP A 157 -1.96 68.40
REMARK 500 PHE A 230 -60.87 -90.61
REMARK 500 THR A 280 -63.74 -94.46
REMARK 500 ASN A 390 -17.57 -143.32
REMARK 500 SER A 432 -6.53 71.86
REMARK 500 MET A 477 49.81 -91.14
REMARK 500 ALA A 478 13.65 -141.02
REMARK 500 ASN A 517 73.98 58.32
REMARK 500 LYS A 535 -51.04 -125.35
REMARK 500 VAL A 713 -56.06 -129.06
REMARK 500 GLU A 748 34.41 -143.01
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue AV0 A 801
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: EMD-12604 RELATED DB: EMDB
REMARK 900 CRYO-EM STRUCTURE OF THE MYCOLIC ACID TRANSPORTER MMPL3 FROM M.
REMARK 900 TUBERCULOSIS
DBREF 7NVH A 1 753 UNP P9WJV5 MMPL3_MYCTU 1 753
SEQADV 7NVH GLY A 754 UNP P9WJV5 EXPRESSION TAG
SEQADV 7NVH SER A 755 UNP P9WJV5 EXPRESSION TAG
SEQADV 7NVH GLU A 756 UNP P9WJV5 EXPRESSION TAG
SEQADV 7NVH ASN A 757 UNP P9WJV5 EXPRESSION TAG
SEQADV 7NVH LEU A 758 UNP P9WJV5 EXPRESSION TAG
SEQADV 7NVH TYR A 759 UNP P9WJV5 EXPRESSION TAG
SEQADV 7NVH PHE A 760 UNP P9WJV5 EXPRESSION TAG
SEQADV 7NVH GLN A 761 UNP P9WJV5 EXPRESSION TAG
SEQRES 1 A 761 MET PHE ALA TRP TRP GLY ARG THR VAL TYR ARG TYR ARG
SEQRES 2 A 761 PHE ILE VAL ILE GLY VAL MET VAL ALA LEU CYS LEU GLY
SEQRES 3 A 761 GLY GLY VAL PHE GLY LEU SER LEU GLY LYS HIS VAL THR
SEQRES 4 A 761 GLN SER GLY PHE TYR ASP ASP GLY SER GLN SER VAL GLN
SEQRES 5 A 761 ALA SER VAL LEU GLY ASP GLN VAL TYR GLY ARG ASP ARG
SEQRES 6 A 761 SER GLY HIS ILE VAL ALA ILE PHE GLN ALA PRO ALA GLY
SEQRES 7 A 761 LYS THR VAL ASP ASP PRO ALA TRP SER LYS LYS VAL VAL
SEQRES 8 A 761 ASP GLU LEU ASN ARG PHE GLN GLN ASP HIS PRO ASP GLN
SEQRES 9 A 761 VAL LEU GLY TRP ALA GLY TYR LEU ARG ALA SER GLN ALA
SEQRES 10 A 761 THR GLY MET ALA THR ALA ASP LYS LYS TYR THR PHE VAL
SEQRES 11 A 761 SER ILE PRO LEU LYS GLY ASP ASP ASP ASP THR ILE LEU
SEQRES 12 A 761 ASN ASN TYR LYS ALA ILE ALA PRO ASP LEU GLN ARG LEU
SEQRES 13 A 761 ASP GLY GLY THR VAL LYS LEU ALA GLY LEU GLN PRO VAL
SEQRES 14 A 761 ALA GLU ALA LEU THR GLY THR ILE ALA THR ASP GLN ARG
SEQRES 15 A 761 ARG MET GLU VAL LEU ALA LEU PRO LEU VAL ALA VAL VAL
SEQRES 16 A 761 LEU PHE PHE VAL PHE GLY GLY VAL ILE ALA ALA GLY LEU
SEQRES 17 A 761 PRO VAL MET VAL GLY GLY LEU CYS ILE ALA GLY ALA LEU
SEQRES 18 A 761 GLY ILE MET ARG PHE LEU ALA ILE PHE GLY PRO VAL HIS
SEQRES 19 A 761 TYR PHE ALA GLN PRO VAL VAL SER LEU ILE GLY LEU GLY
SEQRES 20 A 761 ILE ALA ILE ASP TYR GLY LEU PHE ILE VAL SER ARG PHE
SEQRES 21 A 761 ARG GLU GLU ILE ALA GLU GLY TYR ASP THR GLU THR ALA
SEQRES 22 A 761 VAL ARG ARG THR VAL ILE THR ALA GLY ARG THR VAL THR
SEQRES 23 A 761 PHE SER ALA VAL LEU ILE VAL ALA SER ALA ILE GLY LEU
SEQRES 24 A 761 LEU LEU PHE PRO GLN GLY PHE LEU LYS SER LEU THR TYR
SEQRES 25 A 761 ALA THR ILE ALA SER VAL MET LEU SER ALA ILE LEU SER
SEQRES 26 A 761 ILE THR VAL LEU PRO ALA CYS LEU GLY ILE LEU GLY LYS
SEQRES 27 A 761 HIS VAL ASP ALA LEU GLY VAL ARG THR LEU PHE ARG VAL
SEQRES 28 A 761 PRO PHE LEU ALA ASN TRP LYS ILE SER ALA ALA TYR LEU
SEQRES 29 A 761 ASN TRP LEU ALA ASP ARG LEU GLN ARG THR LYS THR ARG
SEQRES 30 A 761 GLU GLU VAL GLU ALA GLY PHE TRP GLY LYS LEU VAL ASN
SEQRES 31 A 761 ARG VAL MET LYS ARG PRO VAL LEU PHE ALA ALA PRO ILE
SEQRES 32 A 761 VAL ILE ILE MET ILE LEU LEU ILE ILE PRO VAL GLY LYS
SEQRES 33 A 761 LEU SER LEU GLY GLY ILE SER GLU LYS TYR LEU PRO PRO
SEQRES 34 A 761 THR ASN SER VAL ARG GLN ALA GLN GLU GLU PHE ASP LYS
SEQRES 35 A 761 LEU PHE PRO GLY TYR ARG THR ASN PRO LEU THR LEU VAL
SEQRES 36 A 761 ILE GLN THR SER ASN HIS GLN PRO VAL THR ASP ALA GLN
SEQRES 37 A 761 ILE ALA ASP ILE ARG SER LYS ALA MET ALA ILE GLY GLY
SEQRES 38 A 761 PHE ILE GLU PRO ASP ASN ASP PRO ALA ASN MET TRP GLN
SEQRES 39 A 761 GLU ARG ALA TYR ALA VAL GLY ALA SER LYS ASP PRO SER
SEQRES 40 A 761 VAL ARG VAL LEU GLN ASN GLY LEU ILE ASN PRO ALA ASP
SEQRES 41 A 761 ALA SER LYS LYS LEU THR GLU LEU ARG ALA ILE THR PRO
SEQRES 42 A 761 PRO LYS GLY ILE THR VAL LEU VAL GLY GLY THR PRO ALA
SEQRES 43 A 761 LEU GLU LEU ASP SER ILE HIS GLY LEU PHE ALA LYS MET
SEQRES 44 A 761 PRO LEU MET VAL VAL ILE LEU LEU THR THR THR ILE VAL
SEQRES 45 A 761 LEU MET PHE LEU ALA PHE GLY SER VAL VAL LEU PRO ILE
SEQRES 46 A 761 LYS ALA THR LEU MET SER ALA LEU THR LEU GLY SER THR
SEQRES 47 A 761 MET GLY ILE LEU THR TRP ILE PHE VAL ASP GLY HIS PHE
SEQRES 48 A 761 SER LYS TRP LEU ASN PHE THR PRO THR PRO LEU THR ALA
SEQRES 49 A 761 PRO VAL ILE GLY LEU ILE ILE ALA LEU VAL PHE GLY LEU
SEQRES 50 A 761 SER THR ASP TYR GLU VAL PHE LEU VAL SER ARG MET VAL
SEQRES 51 A 761 GLU ALA ARG GLU ARG GLY MET SER THR GLN GLU ALA ILE
SEQRES 52 A 761 ARG ILE GLY THR ALA ALA THR GLY ARG ILE ILE THR ALA
SEQRES 53 A 761 ALA ALA LEU ILE VAL ALA VAL VAL ALA GLY ALA PHE VAL
SEQRES 54 A 761 PHE SER ASP LEU VAL MET MET LYS TYR LEU ALA PHE GLY
SEQRES 55 A 761 LEU MET ALA ALA LEU LEU LEU ASP ALA THR VAL VAL ARG
SEQRES 56 A 761 MET PHE LEU VAL PRO SER VAL MET LYS LEU LEU GLY ASP
SEQRES 57 A 761 ASP CYS TRP TRP ALA PRO ARG TRP ALA ARG ARG LEU GLN
SEQRES 58 A 761 THR ARG ILE GLY LEU GLY GLU ILE HIS LEU PRO ASP GLY
SEQRES 59 A 761 SER GLU ASN LEU TYR PHE GLN
HET AV0 A 801 69
HETNAM AV0 LAURYL MALTOSE NEOPENTYL GLYCOL
HETSYN AV0 2,2-DIDECYLPROPANE-1,3-BIS-B-D-MALTOPYRANOSIDE; 2-
HETSYN 2 AV0 DECYL-2-{[(4-O-ALPHA-D-GLUCOPYRANOSYL-BETA-D-
HETSYN 3 AV0 GLUCOPYRANOSYL)OXY]METHYL}DODECYL4-O-ALPHA-D-
HETSYN 4 AV0 GLUCOPYRANOSYL-BETA-D-GLUCOPYRANOSIDE
FORMUL 2 AV0 C47 H88 O22
HELIX 1 AA1 MET A 1 TYR A 12 1 12
HELIX 2 AA2 VAL A 21 GLY A 26 1 6
HELIX 3 AA3 PHE A 30 LEU A 32 5 3
HELIX 4 AA4 SER A 33 HIS A 37 1 5
HELIX 5 AA5 SER A 48 GLY A 62 1 15
HELIX 6 AA6 ASP A 83 ASN A 95 1 13
HELIX 7 AA7 ALA A 117 ALA A 121 5 5
HELIX 8 AA8 ASP A 138 ALA A 148 1 11
HELIX 9 AA9 ILE A 149 GLN A 154 1 6
HELIX 10 AB1 ARG A 155 GLY A 159 5 5
HELIX 11 AB2 GLY A 165 GLY A 175 1 11
HELIX 12 AB3 GLY A 175 GLY A 201 1 27
HELIX 13 AB4 GLY A 202 ALA A 228 1 27
HELIX 14 AB5 PHE A 236 GLY A 247 1 12
HELIX 15 AB6 GLY A 247 GLU A 266 1 20
HELIX 16 AB7 ASP A 269 GLY A 298 1 30
HELIX 17 AB8 LEU A 299 PHE A 302 5 4
HELIX 18 AB9 GLN A 304 GLY A 337 1 34
HELIX 19 AC1 LYS A 338 ASP A 341 5 4
HELIX 20 AC2 PHE A 384 VAL A 392 1 9
HELIX 21 AC3 ALA A 400 LEU A 409 1 10
HELIX 22 AC4 ILE A 411 LYS A 416 5 6
HELIX 23 AC5 SER A 423 LEU A 427 5 5
HELIX 24 AC6 VAL A 433 PHE A 444 1 12
HELIX 25 AC7 THR A 465 MET A 477 1 13
HELIX 26 AC8 ASP A 488 MET A 492 5 5
HELIX 27 AC9 ASN A 517 ALA A 519 5 3
HELIX 28 AD1 ASP A 520 ARG A 529 1 10
HELIX 29 AD2 THR A 544 ALA A 557 1 14
HELIX 30 AD3 LYS A 558 PHE A 578 1 21
HELIX 31 AD4 VAL A 581 VAL A 607 1 27
HELIX 32 AD5 PHE A 611 ASN A 616 1 6
HELIX 33 AD6 THR A 623 ARG A 655 1 33
HELIX 34 AD7 SER A 658 THR A 670 1 13
HELIX 35 AD8 THR A 670 PHE A 690 1 21
HELIX 36 AD9 LEU A 693 VAL A 713 1 21
HELIX 37 AE1 VAL A 713 GLY A 727 1 15
HELIX 38 AE2 ASP A 728 TRP A 732 5 5
HELIX 39 AE3 PRO A 734 ILE A 744 1 11
SHEET 1 AA1 2 VAL A 38 THR A 39 0
SHEET 2 AA1 2 VAL A 233 HIS A 234 1 O VAL A 233 N THR A 39
SHEET 1 AA2 4 ALA A 109 GLY A 110 0
SHEET 2 AA2 4 TYR A 127 SER A 131 -1 O SER A 131 N ALA A 109
SHEET 3 AA2 4 VAL A 70 GLN A 74 -1 N PHE A 73 O THR A 128
SHEET 4 AA2 4 LYS A 162 ALA A 164 -1 O ALA A 164 N VAL A 70
SHEET 1 AA3 4 GLN A 494 GLU A 495 0
SHEET 2 AA3 4 VAL A 508 GLY A 514 -1 O GLN A 512 N GLN A 494
SHEET 3 AA3 4 PRO A 451 GLN A 457 -1 N LEU A 452 O ASN A 513
SHEET 4 AA3 4 LEU A 540 GLY A 543 -1 O LEU A 540 N VAL A 455
SITE 1 AC1 20 GLN A 40 SER A 41 TYR A 44 VAL A 51
SITE 2 AC1 20 SER A 54 ASP A 58 ASP A 139 GLY A 165
SITE 3 AC1 20 LEU A 166 VAL A 169 THR A 174 ILE A 177
SITE 4 AC1 20 HIS A 234 TYR A 235 PHE A 236 ILE A 422
SITE 5 AC1 20 GLN A 437 ARG A 448 ASN A 450 GLU A 548
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000